Scientists test new version of Weight-Loss drug
NCT ID NCT07221591
Summary
This study aims to compare how two different versions of the experimental obesity drug survodutide are absorbed by the body. About 100 healthy adults with a higher body weight will inject one of the two drug formulations weekly for about six and a half months. Researchers will measure drug levels in the blood to see if the new version works similarly to the original.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CRS Clinical Research Services Berlin GmbH
Berlin, 13627, Germany
-
CRS Clinical Research Services Mannheim GmbH
Mannheim, 68167, Germany
Conditions
Explore the condition pages connected to this study.